New England Research & Management, Inc. Baxter International Inc Transaction History

New England Research & Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 06, 2022	SELL	$53.86 - $66.8 $10,772 - $13,360	-200 Reduced 1.57%	12,515 $674,000
Q2 2022 Jul 20, 2022	BUY	$63.83 - $80.0 $811,598 - $1.02 Million	12,715 New	12,715 $817,000
Q3 2019 Nov 04, 2019	SELL	$81.4 - $89.78 $516,890 - $570,103	-6,350 Closed	0 $0
Q2 2019 Jul 09, 2019	BUY	$73.44 - $82.41 $466,344 - $523,303	6,350 New	6,350 $520,000
Q1 2019 Apr 03, 2019	SELL	$64.48 - $81.31 $1.08 Million - $1.36 Million	-16,750 Closed	0 $0
Q4 2018 Jan 11, 2019	BUY	$61.45 - $77.8 $1.03 Million - $1.3 Million	16,750 New	16,750 $1.1 Million

996

449M

1.97M

3.04M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $18.2B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of New England Research & Management, Inc., based on Form 13F filings with the SEC.

Stay updated on New England Research & Management, Inc. with notifications on news.